Susquehanna International Group, LLP Cyclerion Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 16, 2023	SELL	$0.43 - $0.9 $9,073 - $18,990	-21,100 Reduced 19.78%	85,600 $36,000
Q4 2022 Feb 14, 2023	BUY	$0.42 - $18.8 $924 - $41,360	2,200 Added 2.11%	106,700 $70,000
Q3 2022 Nov 14, 2022	BUY	$0.58 - $18.2 $1,160 - $36,400	2,000 Added 1.95%	104,500 $90,000
Q2 2022 Aug 15, 2022	BUY	$0.47 - $1.29 $9,635 - $26,445	20,500 Added 25.0%	102,500 $56,000
Q1 2022 May 16, 2022	SELL	$0.96 - $1.78 $3,552 - $6,586	-3,700 Reduced 4.32%	82,000 $91,000
Q4 2021 Feb 14, 2022	SELL	$1.56 - $2.99 $30,732 - $58,903	-19,700 Reduced 18.69%	85,700 $147,000
Q3 2021 Nov 15, 2021	BUY	$2.73 - $4.13 $115,752 - $175,112	42,400 Added 67.3%	105,400 $324,000
Q2 2021 Aug 11, 2021	BUY	$2.18 - $4.29 $137,340 - $270,270	63,000 New	63,000 $246,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $139M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.